M EN2 Pill - pink capsule/oblong
Pill with imprint M EN2 is Pink, Capsule/Oblong and has been identified as Eprosartan Mesylate 400 mg. It is supplied by Matrix Laboratories Limited .
Eprosartan is used in the treatment of High Blood Pressure and belongs to the drug class angiotensin receptor blockers. There is positive evidence of human fetal risk during pregnancy. Eprosartan 400 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for M EN2
Eprosartan Mesylate
- Imprint
- M EN2
- Strength
- 400 mg
- Color
- Pink
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Angiotensin receptor blockers
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Matrix Laboratories Limited
- National Drug Code (NDC)
- 00378-6628
- Inactive Ingredients
-
ammonia,
ferrosoferric oxide,
silicon dioxide,
crospovidone,
hydroxypropyl cellulose,
hypromelloses,
lactose monohydrate,
magnesium stearate,
microcrystalline cellulose,
polyethylene glycol,
polysorbate 80,
povidone,
corn starch,
propylene glycol,
ferric oxide red,
shellac,
titanium dioxide,
ferric oxide yellow
Note: Inactive ingredients may vary.
More about eprosartan
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: angiotensin receptor blockers
- Breastfeeding
Patient resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.